Solvay Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SOLVAY
SOLVAY has sixty-three approved drugs.
Drugs and US Patents for Solvay
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | PORTALAC | lactulose | SOLUTION;ORAL, RECTAL | 072374-001 | Mar 22, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Solvay | RESERPINE | reserpine | TABLET;ORAL | 080446-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Solvay | LACTULOSE | lactulose | SOLUTION;ORAL, RECTAL | 017906-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Solvay | CIN-QUIN | quinidine sulfate | CAPSULE;ORAL | 085297-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Solvay | BUTABARBITAL SODIUM | butabarbital sodium | TABLET;ORAL | 083896-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Solvay
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Solvay | LUVOX | fluvoxamine maleate | TABLET;ORAL | 020243-001 | Dec 5, 1994 | 4,085,225 | ⤷ Start Trial |
| Solvay | LUVOX | fluvoxamine maleate | TABLET;ORAL | 020243-004 | Dec 5, 1994 | 4,085,225 | ⤷ Start Trial |
| Solvay | LUVOX | fluvoxamine maleate | TABLET;ORAL | 020243-003 | Dec 5, 1994 | 4,085,225 | ⤷ Start Trial |
| Solvay | LUVOX | fluvoxamine maleate | TABLET;ORAL | 020243-002 | Dec 5, 1994 | 4,085,225 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |

